[Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian

Haiyan Ye1, Jianguo Chen, Xiaosui Huang

  • 1Department of Gynecology, Medical Research Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China. yehaiyan5413@139.com

Abstract

Insights

Let-7d microRNA significantly reduces ovarian cancer cell proliferation and increases apoptosis by downregulating HMGA2 expression. This study highlights let-7d as a key regulator of ovarian cancer cell behavior.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Context:

  • Ovarian cancer is a leading cause of cancer-related deaths in women.
  • Aberrant expression of microRNAs (miRNAs) and high mobility group AT-hook 2 (HMGA2) are implicated in ovarian cancer progression.
  • Understanding the regulatory mechanisms of ovarian cancer cell behavior is crucial for developing effective therapies.

Purpose:

  • To investigate the role of let-7d in regulating the biological behavior of ovarian cancer cells.
  • To determine the effect of let-7d on the expression of HMGA2 and ras proteins in ovarian cancer cells.
  • To assess the impact of let-7d overexpression on ovarian cancer cell proliferation and apoptosis.

Summary:

  • Let-7d was overexpressed in IGROV1 ovarian cancer cells using a synthesized pre-let-7d sequence in a pcDNA6.2GW/EmGFPmiR vector.
  • Quantitative RT-PCR and Western blotting confirmed that let-7d overexpression significantly reduced HMGA2 mRNA and protein levels, with a less pronounced effect on ras protein.
  • MTT assays and flow cytometry demonstrated that let-7d-induced suppression of HMGA2 led to decreased IGROV1 cell proliferation and increased apoptosis.

Impact:

  • Let-7d acts as a tumor suppressor in ovarian cancer by regulating HMGA2 expression.
  • Overexpression of let-7d can alter the malignant phenotype of ovarian cancer cells, suggesting therapeutic potential.
  • This research provides insights into the molecular mechanisms underlying ovarian cancer development and offers a potential target for miRNA-based therapies.